Nuclear Medicine Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Single-Photon Emission Computed Tomography (SPECT),Positron Emission Tomography (PET)), By Application (Hospitals,Imaging Centers,Academic & Research Institutes), Regional Insights and Forecast to 2035

Nuclear Medicine Equipment Market Overview

Global Nuclear Medicine Equipment Market valued at USD 2284.04 Million in 2026, projected to reach USD 2925.24 Million by 2035, growing at a CAGR of 2.79%.

The Nuclear Medicine Equipment Market is experiencing rapid expansion, with over 6,800 nuclear imaging systems installed globally by the end of 2024. More than 72% of these systems support hybrid modalities such as PET/CT and SPECT/CT. Around 65% of global hospitals now offer nuclear imaging services. In 2024, over 48 million nuclear imaging procedures were conducted, primarily for oncology, cardiology, and neurology. Over 430 active cyclotron facilities globally produce isotopes for diagnostic imaging. More than 80 countries have adopted nuclear medicine imaging into standard medical protocols, signifying the market’s broad integration into modern healthcare.

The United States accounted for over 13,000 nuclear medicine professionals and conducted more than 18.6 million nuclear imaging procedures in 2024. Over 2,700 nuclear imaging systems are operational in U.S. hospitals and diagnostic centers. PET scans represented nearly 56% of diagnostic volume in oncology. The country has more than 210 cyclotron facilities supporting local isotope production. Around 72% of teaching hospitals offer dedicated nuclear medicine departments. Federal health initiatives facilitated funding for over 120 nuclear imaging expansion projects in 2024 alone. The U.S. continues to lead in clinical trials involving nuclear diagnostics and therapeutics integration.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 63% of global demand is driven by rising cancer diagnosis rates and adoption of hybrid imaging modalities across healthcare settings.
• Major Market Restraint: 46% of institutions cite radioisotope supply instability and logistical challenges as primary barriers to nuclear medicine expansion.
• Emerging Trends: 52% of newly installed systems globally are integrated with AI and molecular imaging software for advanced diagnostic accuracy.
• Regional Leadership: North America accounts for 38% of the global market share, followed by Europe at 27% and Asia-Pacific at 22%.
• Competitive Landscape: The top five companies control 61% of the market based on device installations, product innovation, and hospital partnerships.
• Market Segmentation: Hospitals make up 57% of total system installations, imaging centers account for 30%, and academic institutes represent 13%.
• Recent Development: Between 2023 and 2025, over 270 nuclear medicine equipment-related patents were filed, with 43% focused on PET system advancements.

Nuclear Medicine Equipment Market Latest Trends

The Nuclear Medicine Equipment Market is undergoing transformation with AI-integrated diagnostic imaging and radiopharmaceutical compatibility. Over 2,400 hybrid systems combining PET and CT or SPECT and CT were installed globally in 2024. The use of time-of-flight PET technology increased by 37%, enabling more accurate detection of minute lesions. Demand for cardiac SPECT imaging grew by 21% in cardiovascular risk populations. In oncology, PET/CT systems supported over 62% of imaging referrals for cancer staging and treatment assessment. Software-driven 3D quantification tools were installed in 48% of new nuclear medicine systems in 2024, enabling more reliable diagnostic outcomes. Additionally, 17% of imaging systems are now supported by cloud-based reporting platforms. Mobile nuclear medicine units accounted for 9% of rural healthcare deployments globally. Radiology departments in 46 countries invested in AI-assisted interpretation tools, especially in breast, thyroid, and neurological imaging. Molecular imaging adoption among outpatient clinics grew by 24%, reflecting a shift from inpatient-only procedures. This reflects increasing market preference for high-resolution, time-saving, and multi-disease diagnostic tools.

Nuclear Medicine Equipment Market Dynamics

DRIVER

"Rising demand for cancer and cardiac diagnostic procedures"

The growing prevalence of chronic illnesses like cancer and cardiovascular disease is significantly driving nuclear medicine equipment installations. In 2024, over 18 million nuclear imaging procedures were performed for oncology globally. Cardiac SPECT imaging supported 9.2 million cardiac risk assessments. Breast cancer-specific PET scans grew by 27% in diagnostic use. Over 84% of tertiary care hospitals now possess at least one nuclear imaging device. In the U.S., 63% of all PET scans are directed toward oncology. Moreover, around 38 countries updated their clinical protocols to recommend nuclear imaging as a first-line diagnostic for certain cancers.

RESTRAINT

"High dependency on radioactive isotopes"

One of the primary market restraints remains the complex logistics and short half-life of key radioisotopes. In 2024, nearly 40% of global healthcare providers experienced isotope delivery delays. Molybdenum-99 shortages affected over 1.2 million procedures worldwide. Supply disruptions across 6 major production reactors created inconsistencies in patient scheduling. The reliance on international isotope transport, especially for Technetium-99m, created regulatory and customs challenges in more than 20 countries. Alternative sources like cyclotron-based isotopes only covered 22% of demand, emphasizing market vulnerability.

OPPORTUNITY

"Technological integration and AI-enhanced imaging"

Opportunities in the Nuclear Medicine Equipment Market are largely driven by digital transformation. Over 3,000 imaging centers upgraded to software-driven reconstruction algorithms in 2024. AI-based diagnostic interpretation was integrated into 34% of newly sold PET/CT systems. Fusion imaging capabilities, combining nuclear with MRI or CT, saw a 44% year-on-year increase in adoption. Cloud-based access to patient imaging archives expanded to over 2,200 facilities globally. These trends open pathways for scalable diagnostics in both developed and emerging healthcare infrastructures.

CHALLENGE

"Equipment cost and limited accessibility"

High acquisition and maintenance costs for advanced systems present significant market challenges. PET/CT machines can cost upwards of USD 1.2 million per unit, limiting accessibility for mid-scale hospitals. In 2024, only 17% of rural hospitals in emerging economies could afford such investments. Training and licensing requirements for nuclear technicians remain stringent, with over 30% of facilities reporting staffing shortages. Additionally, limited reimbursement policies in over 25 healthcare systems discourage wider nuclear imaging use, further hindering penetration in underfunded regions.

Nuclear Medicine Equipment Market Segmentation

The Nuclear Medicine Equipment Market is segmented by modality and application. Modality is split between SPECT and PET systems, each catering to distinct clinical imaging needs, while applications range from hospitals and imaging centers to academic research.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Single-Photon Emission Computed Tomography (SPECT): SPECT systems represent the majority, with over 10,800 units installed globally by 2024. Cardiology, bone scans, and thyroid imaging accounted for 74% of procedures. SPECT is present in over 78% of nuclear-enabled hospitals worldwide. Dual-head gamma cameras made up 56% of recent SPECT installations, while triple-head systems contributed to higher-resolution neurological imaging. New software upgrades enabled quantitative analysis in 33% of SPECT installations by 2024.

The SPECT segment in the Nuclear Medicine Equipment Market is projected to reach USD 1,826.21 million by 2034, growing from USD 1,459.76 million in 2025, holding a 64.2% market share with a CAGR of 2.47%.

Top 5 Major Dominant Countries in the SPECT Segment

• United States: The U.S. will lead with USD 589.39 million by 2034, capturing 32.27% share and 2.45% CAGR, driven by cardiac and neurological scan demand across hospitals and imaging centers.
• Germany: Germany is projected to reach USD 174.84 million by 2034, holding 9.57% share and 2.36% CAGR due to high clinical use in oncology.
• Japan: Japan will achieve USD 159.67 million by 2034 with 8.75% share and 2.33% CAGR, supported by bone scan procedures and academic installations.
• India: India is expected to reach USD 135.79 million in 2034, accounting for 7.43% share with 2.64% CAGR as hospital adoption widens.
• France: France will grow to USD 128.32 million by 2034, maintaining 7.03% share and 2.29% CAGR, with nuclear cardiology procedures fueling demand.

Positron Emission Tomography (PET): PET systems, with around 4,600 units installed globally, offer superior resolution for metabolic imaging, particularly in oncology. Over 62% of PET scans conducted in 2024 were used for cancer diagnosis or treatment monitoring. Time-of-flight technology was featured in 52% of newly installed PET systems. Around 41% of PET systems are now combined with CT, enhancing anatomical localization. Digital PET technology penetration increased by 26%, with several regions adopting it as a standard.

The PET segment will grow from USD 762.28 million in 2025 to USD 1,019.63 million by 2034, capturing a 35.8% market share with a CAGR of 3.41% led by rising oncology and neurology applications.

Top 5 Major Dominant Countries in the PET Segment

• United States: The U.S. will dominate with USD 404.71 million by 2034, contributing 39.69% share and 3.42% CAGR due to high cancer scan volumes.
• China: China will grow to USD 158.96 million by 2034, securing 15.59% share with 3.68% CAGR amid expanding tertiary healthcare networks.
• Germany: Germany is projected at USD 107.49 million by 2034, accounting for 10.54% share with 3.24% CAGR, driven by oncology and brain imaging applications.
• Japan: Japan will reach USD 95.82 million by 2034, maintaining 9.4% share and 3.16% CAGR due to strong research facility demand.
• India: India will achieve USD 85.91 million by 2034, holding 8.42% share and 3.65% CAGR with growing PET-CT deployment across metropolitan hospitals.

BY APPLICATION

Hospitals: Hospitals account for nearly 57% of all nuclear medicine equipment installations, with over 9,000 devices active in general and specialty hospitals globally. In 2024, hospital-based facilities performed approximately 27 million nuclear imaging procedures. Oncology and cardiology departments represent the highest demand generators within hospital systems. Nearly 82% of large public hospitals have upgraded to hybrid imaging modalities.

The hospital segment is forecasted to reach USD 1,681.59 million by 2034, up from USD 1,330.82 million in 2025, capturing 59.1% share with a CAGR of 2.62%, driven by increased adoption in cardiology and oncology departments.

Top 5 Major Dominant Countries in the Hospitals Application

• United States: The U.S. will dominate with USD 598.72 million by 2034, taking 35.6% share and 2.61% CAGR as public and private hospitals expand nuclear medicine units.
• Germany: Germany will post USD 162.53 million by 2034, capturing 9.66% share with 2.55% CAGR due to universal healthcare-backed imaging adoption.
• India: India will reach USD 147.83 million, holding 8.79% share with 2.87% CAGR from public hospital upgrades.
• Japan: Japan will register USD 138.62 million, maintaining 8.24% share and 2.49% CAGR led by long-term disease monitoring needs.
• France: France is projected at USD 130.39 million by 2034, securing 7.75% share with 2.41% CAGR from cardiovascular and cancer diagnostic expansion.

Imaging Centers; Imaging centers represent 30% of the application market, with around 4,800 nuclear medicine systems deployed globally. These centers performed approximately 14.4 million scans in 2024. Around 61% of installations are PET/CT devices used for outpatient diagnostics. Independent centers in the U.S., Germany, and South Korea are expanding by offering AI-integrated nuclear imaging to reduce scan times by 20%.

Imaging centers are estimated to grow from USD 612.71 million in 2025 to USD 810.54 million by 2034, accounting for 28.5% share with a CAGR of 3.22%, boosted by outpatient diagnostic demand and hybrid system adoption.

Top 5 Major Dominant Countries in the Imaging Centers Application

• United States: The U.S. will hit USD 322.38 million by 2034, holding 39.76% share and 3.21% CAGR through PET/CT integrations in standalone centers.
• Germany: Germany will achieve USD 94.87 million by 2034, contributing 11.71% share and 3.12% CAGR, supported by high scan frequency.
• China: China is expected at USD 81.23 million by 2034, capturing 10.02% share with 3.44% CAGR amid private imaging expansion.
• Japan: Japan will reach USD 72.98 million, maintaining 9% share and 3.05% CAGR as imaging infrastructure modernizes.
• India: India will post USD 66.41 million by 2034, representing 8.2% share and 3.38% CAGR due to urban diagnostic center growth.

Academic & Research Institutes: Academic and research institutions make up 13% of the market, utilizing nearly 2,100 systems globally. In 2024, these institutions conducted over 6 million experimental and research-based scans. More than 78 universities now offer degree programs in nuclear medicine technology. Research imaging has expanded to include pre-clinical trials for radiotheranostics and advanced drug development platforms.

Academic & research institutes will grow from USD 278.51 million in 2025 to USD 353.71 million in 2034, accounting for 12.4% market share with a CAGR of 2.66%, supported by radiopharmaceutical research and clinical education.

Top 5 Major Dominant Countries in the Academic & Research Institutes Application

• United States: The U.S. will lead with USD 127.00 million by 2034, achieving 35.9% share and 2.64% CAGR through university-led nuclear medicine R&D.
• Japan: Japan will reach USD 61.29 million, representing 17.3% share with 2.57% CAGR due to research grants and innovation centers.
• Germany: Germany is projected at USD 47.44 million by 2034, holding 13.4% share and 2.48% CAGR from collaborative trials.
• India: India will hit USD 44.27 million by 2034, capturing 12.5% share and 2.84% CAGR via radiology training programs.
• China: China will grow to USD 40.33 million, maintaining 11.4% share and 2.92% CAGR from nuclear diagnostics research expansion.

Nuclear Medicine Equipment Market Regional Outlook

The global Nuclear Medicine Equipment Market demonstrates varying adoption patterns across regions, driven by healthcare infrastructure, reimbursement policies, and clinical awareness of nuclear imaging modalities.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds the largest regional share of the global Nuclear Medicine Equipment Market, accounting for 38% of total global installations in 2024. The region had over 4,900 active nuclear imaging systems, with the United States contributing more than 85% of that total. Canada installed approximately 390 new systems between 2023 and 2024. The U.S. conducted 18.6 million nuclear procedures, representing 39% of global volume. PET/CT systems make up 62% of newly procured devices in the region, and around 1,300 hospitals have upgraded to digital detectors. Nuclear cardiology remains a major application area, with more than 5 million procedures performed in 2024. Government-funded healthcare centers across 28 states adopted time-of-flight PET scanners for early cancer detection. Public-private partnerships have fueled infrastructure development, and more than 1,200 outpatient clinics across North America now include molecular imaging diagnostics.

North America will lead the global Nuclear Medicine Equipment Market with an estimated market size of USD 1,081.34 million by 2034, rising from USD 850.21 million in 2025, holding 38% share with a CAGR of 2.67%, driven by hybrid PET/SPECT adoption and research investments.

North America - Major Dominant Countries in the “Nuclear Medicine Equipment Market”

• United States: The U.S. will reach USD 1,030.10 million by 2034, commanding 95.3% regional share with 2.69% CAGR due to advanced diagnostics infrastructure.
• Canada: Canada will grow to USD 34.58 million, representing 3.2% share and 2.51% CAGR through rural imaging center development.
• Mexico: Mexico is projected at USD 11.17 million in 2034, holding 1.03% share with 2.43% CAGR, driven by urban hospital upgrades.
• Cuba: Cuba will reach USD 3.72 million by 2034, contributing 0.34% share and 2.46% CAGR through government healthcare reforms.
• Panama: Panama is estimated at USD 1.77 million in 2034, accounting for 0.16% share with 2.39% CAGR via academic institute expansion.

EUROPE

Europe accounted for 27% of the global Nuclear Medicine Equipment Market in 2024, supported by over 4,100 installed units across 30+ countries. Germany leads the region with approximately 1,120 systems, followed by France and the United Kingdom, each hosting more than 850 units. SPECT systems make up 69% of installations, primarily used in cardiology and orthopedic imaging. Around 47% of hospitals in Europe now operate PET/CT scanners, with oncology being the dominant diagnostic area. In 2024, over 13.1 million nuclear medicine procedures were conducted in Europe. The EU launched over 56 nuclear medicine R&D initiatives between 2023 and 2024, investing in theranostics and isotope supply chains. Adoption of AI-assisted interpretation tools increased by 29% year-on-year. Additionally, 41% of newly established imaging centers were located in Eastern Europe, reflecting growing accessibility.

Europe is projected to reach USD 768.38 million by 2034, growing from USD 604.69 million in 2025 and accounting for 27% of global share, with a CAGR of 2.69% supported by national health programs and aging demographics.

Europe - Major Dominant Countries in the “Nuclear Medicine Equipment Market”

• Germany: Germany will achieve USD 289.21 million by 2034, representing 37.6% regional share with 2.64% CAGR as PET/SPECT centers expand.
• France: France is projected at USD 174.12 million by 2034, capturing 22.6% share and 2.59% CAGR from cardiovascular imaging growth.
• United Kingdom: The UK will grow to USD 122.17 million, contributing 15.8% share and 2.57% CAGR with NHS-driven modernization.
• Italy: Italy will reach USD 109.94 million by 2034, securing 14.3% share and 2.72% CAGR through regional cancer centers.
• Spain: Spain is expected to hit USD 72.94 million in 2034, with 9.5% share and 2.68% CAGR through dual-head SPECT system installations.

ASIA-PACIFIC

Asia-Pacific held a 22% share of the global Nuclear Medicine Equipment Market in 2024, with more than 4,500 systems installed across hospitals and diagnostic facilities. China led the region with approximately 1,980 units, followed by Japan with 1,120, and India with 930 installations. The region performed over 11.2 million nuclear imaging procedures in 2024. PET installations grew by 31%, particularly in oncology centers across South Korea, Australia, and Singapore. Hybrid SPECT/CT systems represented 34% of new installations across the region. More than 85 hospitals in India added nuclear medicine departments in 2024. In Japan, over 640 imaging centers now utilize digital PET for brain and prostate cancer research. Asia-Pacific also has the highest growth in academic research, with over 190 universities offering nuclear medicine education and clinical trials expanding across 14 countries.

Asia’s market is forecasted to reach USD 652.44 million by 2034 from USD 490.23 million in 2025, holding 23% global share and growing at a CAGR of 3.13%, led by large population bases and healthcare infrastructure development.

Asia - Major Dominant Countries in the “Nuclear Medicine Equipment Market”

• China: China will dominate with USD 268.31 million by 2034, accounting for 41.1% of Asia’s market and 3.19% CAGR via high PET/CT demand.
• India: India will reach USD 179.79 million in 2034, with 27.5% share and 3.17% CAGR through rising imaging adoption in Tier 2 cities.
• Japan: Japan is projected at USD 136.81 million by 2034, contributing 21% share and 2.84% CAGR led by academic research institutions.
• South Korea: South Korea will grow to USD 43.63 million, taking 6.7% share and 2.94% CAGR as radiology centers expand.
• Vietnam: Vietnam is forecasted at USD 23.90 million by 2034, representing 3.7% share and 3.11% CAGR via government-led health digitization.

MIDDLE EAST & AFRICA

The Middle East & Africa region accounted for 10% of global Nuclear Medicine Equipment Market share in 2024, with more than 2,200 active systems. Saudi Arabia and UAE jointly held over 950 devices, while South Africa had 420 and Egypt 280. In 2024, around 6.3 million nuclear medicine procedures were conducted across the region. PET/CT systems accounted for 48% of new installations in the Middle East, largely used in cancer screening programs. Public healthcare initiatives supported the development of 12 new nuclear medicine centers in Gulf countries in 2024. South Africa expanded isotope production capacity through reactor upgrades, producing more than 6,000 curies of Technetium-99m. Nigeria and Kenya witnessed double-digit growth in nuclear cardiology units due to increased awareness and regional investments. AI-enabled image processing software was implemented in 17% of newly installed systems in Africa during the same period.

The Middle East and Africa region will grow from USD 276.91 million in 2025 to USD 343.68 million in 2034, accounting for 12% of the global market with a CAGR of 2.41%, supported by public-private investments and rising chronic disease burden.

Middle East and Africa - Major Dominant Countries in the “Nuclear Medicine Equipment Market”

• Saudi Arabia: Saudi Arabia will lead with USD 104.73 million by 2034, holding 30.5% share and 2.46% CAGR from oncology imaging expansion.
• South Africa: South Africa will achieve USD 76.89 million in 2034, securing 22.4% share with 2.39% CAGR via hospital chain upgrades.
• UAE: UAE is projected at USD 61.34 million by 2034, with 17.8% share and 2.43% CAGR due to rising PET installations.
• Egypt: Egypt will reach USD 53.28 million in 2034, representing 15.5% share and 2.35% CAGR with support from health reform initiatives.
• Nigeria: Nigeria is expected at USD 47.44 million, holding 13.8% share and 2.28% CAGR through diagnostic infrastructure projects.

List of Top Nuclear Medicine Equipment Companies

• Neusoft Corporation
• Toshiba Corporation
• Compañía Mexicana de Radiología CGR, S.A de C.V.
• Koninklijke Philips N.V.
• Siemens Aktiengesellschaft
• SurgicEye GmbH
• Mediso Medical Imaging Systems, Ltd
• General Electric Company
• DDD-Diagnostics A/S
• Bozlu Holding
• Digirad Corporation

Top Two Companies by Market Share:

• Siemens Aktiengesellschaft: Siemens leads the market with over 2,700 installed systems worldwide, accounting for approximately 19.4% of global market share by unit volume.
• General Electric Company: GE ranks second with more than 2,400 installations globally, contributing to nearly 17.3% of market share, particularly in the PET/CT and AI-integrated segment.

Investment Analysis and Opportunities

Global investment in the Nuclear Medicine Equipment Market exceeded USD 6.4 billion between 2023 and 2025, with North America capturing 35% of all capital deployments. Over 1,400 imaging centers globally underwent upgrades to hybrid imaging devices, while more than 300 new nuclear medicine facilities were built. In 2024, China announced funding for 115 new nuclear imaging installations, totaling over USD 1.1 billion in provincial healthcare infrastructure. Germany invested in 47 theranostic centers to expand molecular imaging capabilities. AI-powered software integration attracted over USD 800 million in global venture funding during 2023–2024. Key opportunities are found in outpatient and specialized oncology clinics, where scan volumes rose by 24% year-on-year.

New Product Development

Between 2023 and 2025, more than 120 new nuclear imaging systems and enhancements were introduced globally. Siemens launched its Biograph Vision Quadra PET/CT system in 2024, offering whole-body imaging in under five minutes. Philips developed a new digital detector module that improved image resolution by 21% across its Vereos PET/CT platform. Neusoft introduced AI-enhanced SPECT systems tailored for small and medium-sized hospitals. SurgicEye released a mobile gamma camera unit for intraoperative sentinel node detection, with a 98.7% clinical accuracy rate in trials. GE Healthcare unveiled a new Smart Workflow suite integrated with its Discovery MI PET/CT, reducing scan prep time by 32%.

Five Recent Developments

• Siemens installed its 500th Biograph Vision PET/CT scanner globally by Q4 2024, extending its digital PET platform to 64 countries.
• GE Healthcare partnered with 18 hospitals across India to deploy Smart Workflow nuclear imaging platforms by mid-2024.
• Philips completed a project with the NHS in the UK, digitizing over 450 legacy SPECT systems in 2023.
• Mediso launched the AnyScan TRIO in 2025, a triple modality scanner installed in 16 European clinical research centers.
• Neusoft secured a government tender in Brazil for 97 nuclear medicine systems for deployment across public hospitals by late 2025.

Report Coverage

The Nuclear Medicine Equipment Market Report provides detailed analysis of market performance across 60+ countries, covering over 25,000 installed systems worldwide. The report evaluates system types including SPECT, PET, and hybrid modalities. Application segments include hospitals, diagnostic imaging centers, and academic research institutions. The report also tracks radiopharmaceutical compatibility, software integration trends, and global supply chain disruptions. Data insights span over 340 nuclear medicine technology providers, with breakdowns of unit installations, scan volumes, modality adoption, and research activity. Geographic coverage includes regional profiles of North America, Europe, Asia-Pacific, and the Middle East & Africa.

Nuclear Medicine Equipment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2284.04 Million in 2026
Market Size Value By	USD 2925.24 Million by 2035
Growth Rate	CAGR of 2.79% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Single-Photon Emission Computed Tomography (SPECT) Positron Emission Tomography (PET) By Application : Hospitals Imaging Centers Academic & Research Institutes
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample